COCP supply chain intelligence for Cocrystal Pharma, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| H-C-WAINWRIGHT-CO-LLC | H-C-WAINWRIGHT-CO-LLC | 92% | The Company is party to the At-The-Market Offering Agreement, dated July 1, 2020 ("ATM Agreement") with H.C. Wainwright & Co., LLC ("Wainwright"), pursuant to which the Company may issue and sell ove… |
| WAINWRIGHT | WAINWRIGHT | 92% | The Company paid Wainwright consideration consisting of (i) a cash fee equal to 7.0% of the aggregate gross proceeds in the offering, (ii) a management fee equal to 1.0% of the aggregate gross procee… |
| UNITED-KINGDOM-CLINICAL-RESEARCH-ORGANIZATION | UNITED-KINGDOM-CLINICAL-RESEARCH-ORGANIZATION | 85% | A dispute has arisen with the United Kingdom clinical research organization (the "CRO") that performed the Phase 2a study |
| NIMU | Non-Invasive Monitoring Systems, Inc. | 72% | Reciprocal relationship from NIMU graph: Item 13. Certain Relationships and Related Transactions, and Director Independence. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS Dr. Frost is a director and… |
| VXRT | Vaxart, Inc. | 72% | Reciprocal relationship from VXRT graph: Reciprocal relationship from COCP graph: Reciprocal relationship from VXRT graph: Reciprocal relationship from COCP graph: Reciprocal relationship from VXRT g… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| FOUR-INSIDERS-OF-THE-COMPANY | FOUR-INSIDERS-OF-THE-COMPANY | 90% | The investors were four insiders of the Company. |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 90% | USAspending awards from Department of Health and Human Services: $498,199 across 1 awards. 75N93025C00038 DEVELOPMENT OF PAN-INFLUENZA INHIBITORS TARGETING THE PA ENDONUCLEASE FROM THE VIRAL REPLICAT… |
| VXRT | Vaxart, Inc. | 72% | Reciprocal relationship from VXRT graph: ion, any success in preclinical testing we might observe for our COVID-19 vaccine candidates may not be predictive of the results of later-stage human clinica… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| COCP-DEBT-8769 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2018-12-31. |
| COCP-DEBT-8768 | Warrants outstanding: 0 | 90% | xbrl warrant detail from xbrl 2024-12-31. |
| COCP-DEBT | Debt stack $1.4M | 90% | Market cache reports total debt of $1.4M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| COCP-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 263,987; ownership 1.92%; value $269,266; as of 2025-12-31. |
| COCP-OWNER-DRW-SECURITIES-LLC | DRW Securities, LLC | 95% | 13F/ownership overlay lists DRW Securities, LLC; shares held 33,593; ownership 0.24%; value $34,264; as of 2025-12-31. |
| COCP-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | Geode Capital Management, LLC | 95% | 13F/ownership overlay lists Geode Capital Management, LLC; shares held 82,499; ownership 0.60%; value $84,148; as of 2025-12-31. |
| COCP-OWNER-BLACKROCK-INC | Blackrock Inc. | 95% | 13F/ownership overlay lists Blackrock Inc.; shares held 73,746; ownership 0.54%; value $75,220; as of 2025-12-31. |
| COCP-OWNER-T3-COMPANIES-LLC | T3 Companies, LLC | 95% | 13F/ownership overlay lists T3 Companies, LLC; shares held 52,300; ownership 0.38%; value $53,345; as of 2025-12-31. |
| COCP-OWNER-XTX-TOPCO-LTD | Xtx Topco Ltd | 95% | 13F/ownership overlay lists Xtx Topco Ltd; shares held 15,141; ownership 0.11%; value $15,443; as of 2025-12-31. |
| COCP-OWNER-NEUBERGER-BERMAN-GROUP-LLC | Neuberger Berman Group, LLC | 95% | 13F/ownership overlay lists Neuberger Berman Group, LLC; shares held 31,886; ownership 0.23%; value $32,523; as of 2025-12-31. |
| COCP-OWNER-RENAISSANCE-TECHNOLOGIES-LLC | Renaissance Technologies, LLC | 95% | 13F/ownership overlay lists Renaissance Technologies, LLC; shares held 126,028; ownership 0.91%; value $128,548; as of 2025-12-31. |
| COCP-OWNER-STATE-STREET-CORPORATION | State Street Corporation | 95% | 13F/ownership overlay lists State Street Corporation; shares held 20,543; ownership 0.15%; value $20,953; as of 2025-12-31. |
| COCP-OWNER-TWO-SIGMA-SECURITIES-LLC | Two Sigma Securities, LLC | 95% | 13F/ownership overlay lists Two Sigma Securities, LLC; shares held 12,752; ownership 0.09%; value $13,007; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| VXRT | Vaxart, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| NIMU | Non-Invasive Monitoring Systems, Inc. | 100.00 | 1 | ['supplier'] |
| SGIOF | Shionogi & Co., Ltd. | 50.00 | 2 | |
| MRK | Merck & Co., Inc. | 50.00 | 2 | |
| SNYNF | Sanofi | 50.00 | 2 | |
| OPK | OPKO Health, Inc. | 50.00 | 2 | |
| CSLLY | CSL Limited | 50.00 | 2 | |
| HCRP | HCRP | 50.00 | 2 | |
| EBS | Emergent BioSolutions Inc. | 50.00 | 2 |